Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve is a leading cannabis company with a focus on providing relief to patients through trusted products. Hand-grown plants in a natural environment ensure quality and purity at every step. Trulieve is a vertically integrated, multi-state operator with a strong market presence in Arizona, Florida, and Pennsylvania. The company's innovative products, high-quality brands, and commitment to customer experience make it a top choice for those seeking access to cannabis products.
Trulieve Cannabis Corp. (OTCQX: TCNNF) reported record revenue of $318.3 million for Q1 2022, marking a 64% increase year-over-year and a 4% rise sequentially. The gross profit reached $178.2 million with a gross margin of 56%. Despite a net loss of $32.0 million, adjusted net income was $1.7 million. Operationally, Trulieve has an extensive retail network with 165 dispensaries and over 4.0 million square feet of cultivation capacity. The company expects 2022 revenue between $1.3 billion and $1.4 billion.
Trulieve Cannabis Corp. (CSE: TRUL; OTCQX: TCNNF) announced its participation in May 2022 events, highlighting a keynote speech by CEO Kim Rivers at Regenerative Cannabis Live on May 5, 2022. Trulieve is a leading, vertically integrated cannabis company operating in 11 states, focusing on growth and market expansion through its hub strategy. The company aims to provide innovative, high-quality products to enhance customer experiences and access to cannabis.
On April 28, 2022, Trulieve Cannabis Corp. announced that CEO Kim Rivers received the Women's Leadership Award from Green Market Report for her contributions in the cannabis industry. Rivers has driven significant business advancements, including leading retail expansion and the acquisition of Harvest Health. Trulieve also released its first ESG report, marking a milestone in corporate responsibility. The award ceremony took place during the Women's Summit in New York City, highlighting the importance of female leadership in the cannabis sector.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the completion of its acquisition of Greenhouse Wellness West Virginia Dispensaries LLC, which holds a dispensary permit in West Virginia. The acquisition, covered by the West Virginia Department of Health and Human Resources, involved a minimal cash payment. This deal enhances Trulieve's presence in West Virginia, where it now operates ten dispensaries in key locations and plans to open more in the near future. CEO Kim Rivers emphasized the company's commitment to community investment and improved patient access to high-quality products.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Zephyrhills, Florida on April 16, 2022. This dispensary aims to enhance patient access and features grand opening specials, including a 25% discount for registered patients. Trulieve is the leading medical cannabis provider in Florida, offering a wide range of THC and CBD products. The company emphasizes personalized patient care and support through trained retail employees. For more details on Trulieve's operations and other locations, visit trulieve.com.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Fort Myers, Florida, on April 13, 2022. The dispensary, located at 15620 Summerlin Rd, will feature grand opening festivities, including giveaways, food trucks, and a 25% discount for registered patients. As a leading medical cannabis provider, Trulieve offers a diverse range of THC and CBD products in Florida, with a focus on personalized patient care through trained staff. The company aims to build community relationships while expanding access to medical cannabis.
Trulieve Cannabis Corp. has opened its third dispensary in Framingham, Massachusetts on April 3, 2022. This new, 5,000 square foot location aims to provide an elevated in-store experience with a contemporary design. Initially serving adult-use customers, the dispensary will also cater to medical cannabis patients later this Spring. A grand opening celebration is set for April 9, 2022, featuring celebrity appearances and promotional offers. Trulieve continues to expand its footprint in Massachusetts, enhancing customer access to a variety of cannabis products.
Trulieve Cannabis Corp. (OTCQX: TCNNF) has announced its participation in multiple conferences in April 2022, highlighting strategic engagement with investors. CEO Kim Rivers will lead discussions at the BTIG Global Cannabis Conference on April 6, the Cantor Virtual Cannabis Conference on April 14, and the Benzinga Cannabis Capital Conference on April 20, along with a speech at The Green Market Report's Women's Summit on April 28. Trulieve operates in 11 states, focusing on growth in retail and distribution, particularly in Arizona, Florida, and Pennsylvania.
Trulieve Cannabis Corp. announces an exclusive partnership with DeLisioso LLC to produce and sell the Flamingo Kush pre-rolls in Florida, starting April 15, 2022. DeLisioso, founded by Richard DeLisi, focuses on high-end cannabis products and aims to support families affected by the War on Drugs. The partnership allows Trulieve to expand its product offerings as the leading cannabis provider in Florida. Flamingo Kush, an indica-dominant strain, will be available in all Trulieve dispensaries, showcasing DeLisioso's commitment to quality and social impact.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
What is Trulieve's core focus?
Where does Trulieve operate?
What sets Trulieve apart from other cannabis companies?
How does Trulieve ensure product quality?
What is Trulieve's approach to expansion?
